| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/01/1994 | WO1994018964A1 USE OF φ-GUANIDINOCARBOXYLIC ACID ESTERS |
| 09/01/1994 | WO1994018963A1 Method of reversing resistance of hiv-1 strains to zidovudine |
| 09/01/1994 | WO1994018960A1 Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
| 09/01/1994 | WO1994004017A3 New method of treatment |
| 09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
| 09/01/1994 | CA2594184A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/01/1994 | CA2157049A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 09/01/1994 | CA2156916A1 Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
| 09/01/1994 | CA2156420A1 Inhibitors of hiv reverse transcriptase |
| 09/01/1994 | CA2156258A1 Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria |
| 09/01/1994 | CA2155830A1 Substituted azolone derivatives for treating diseases causes by helicobacter |
| 09/01/1994 | CA2155829A1 Method of reversing resistance of hiv-1 strains to zidovudine |
| 08/31/1994 | EP0612844A2 Expression constructs containing HIV inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same |
| 08/31/1994 | EP0612742A1 A physiologically active bisindole-pyrrole derivative |
| 08/31/1994 | EP0612734A1 Novel orally active antifungal agents |
| 08/31/1994 | EP0612731A1 Novel guinolone and naphthyridone derivatives |
| 08/31/1994 | EP0612719A1 Hydroxyalkanecarboxylic acid derivatives |
| 08/31/1994 | EP0612532A2 Canine coronavirus vaccine from feline enteric coronavirus |
| 08/31/1994 | EP0612524A1 Angiotensin II antagonists for the treatment of viral diseases |
| 08/31/1994 | EP0612244A1 Endothelin receptor antagonists |
| 08/31/1994 | EP0612243A1 Bactericidal pharmaceutical composition containing chlorhexidine and eugenol |
| 08/31/1994 | EP0612216A1 Phospholipid antimicrobial compositions |
| 08/31/1994 | EP0505413B1 Beta-lactam derivatives |
| 08/31/1994 | EP0496796B1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 08/31/1994 | CN1091432A Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use |
| 08/31/1994 | CN1091427A Novel compounds |
| 08/31/1994 | CN1091291A Method of treating viral infections |
| 08/30/1994 | US5342846 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents |
| 08/30/1994 | US5342840 Cyclopropane derivative |
| 08/24/1994 | EP0611822A2 More complex type retroviruses having mixed type LTR, and uses thereof |
| 08/24/1994 | EP0611776A2 New pseudopeptides with antiviral activity |
| 08/24/1994 | EP0611397A1 Feline leukemia virus vaccines |
| 08/24/1994 | EP0611304A1 Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 08/24/1994 | EP0535001B1 Composite molecular system for the contra-escalatory treatment of viral infections |
| 08/24/1994 | EP0504191B1 Method and composition for the treatment of mammalian hiv infection |
| 08/24/1994 | EP0301064B1 3'-azido-2',3'-dideoxyuridine anti-retroviral composition |
| 08/24/1994 | CN1091005A Immunopotentiatory agents and physiologically acceptable salts thereof |
| 08/23/1994 | US5340923 Methods for making and purifying antivenoms |
| 08/23/1994 | US5340813 Substituted aminoalkyl xanthine compounds |
| 08/23/1994 | US5340800 Peptide medicaments for the treatment of disease |
| 08/23/1994 | US5340732 Antiviral protein |
| 08/23/1994 | US5339766 Method of introducing material into eggs during early embryonic development |
| 08/23/1994 | CA2116193A1 Physiologically active compound hs-1 and process for the preparation of the same |
| 08/23/1994 | CA1331611C Therapeutic compounds |
| 08/23/1994 | CA1331607C Purinyl and pyrimidinyl cyclobutanes |
| 08/23/1994 | CA1331562C Vaccine |
| 08/21/1994 | CA2115966A1 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof |
| 08/18/1994 | WO1994018327A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/18/1994 | WO1994018311A1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 08/18/1994 | WO1994018208A1 7,42-bis (o-demethyl) rapamycin |
| 08/18/1994 | WO1994018206A1 Rapamycin derivative process for its preparation and its use |
| 08/18/1994 | WO1994018188A1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl[b]pyran-2-ones useful to treat retroviral infections |
| 08/18/1994 | WO1994017822A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
| 08/18/1994 | WO1994017819A1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 08/18/1994 | WO1994017815A1 Therapeutic compounds derived from the neem tree |
| 08/18/1994 | WO1994017773A2 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | WO1994006454A3 Inhibitiion of retrovirus infection |
| 08/18/1994 | DE4311580C1 Glycoproteins, process for their preparation and pharmaceutical compositions containing them |
| 08/18/1994 | CA2155413A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | CA2155109A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | CA2153237A1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl[b]pyran-2-ones useful to treat retroviral infections |
| 08/18/1994 | CA2144320A1 Therapeutic compounds derived from the neem tree |
| 08/18/1994 | CA2115807A1 Purified form of streptogramins, its preparation and pharmaceutical compositions containing same |
| 08/17/1994 | EP0611075A1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| 08/17/1994 | EP0610943A1 Pyridinium derivatives useful as PAF antagonists |
| 08/17/1994 | EP0610436A1 Hepatitis-c virus testing |
| 08/17/1994 | EP0610431A1 Hiv protease inhibitors containing guanidine |
| 08/17/1994 | EP0610377A1 Tri-substituted tetrahydrofuran antifungals |
| 08/17/1994 | EP0610356A1 Diagnosis and treatment of bacterial dysentery |
| 08/17/1994 | EP0610322A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 08/17/1994 | EP0610260A1 Vaccines for actinobacillus pleuropneumoniae |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | EP0530268B1 Process for the preparation of 7-alpha-alkoxycephem derivatives |
| 08/17/1994 | CN1090849A Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and .... |
| 08/17/1994 | CN1090776A Method for the safe administration of fatty acids |
| 08/17/1994 | CN1090757A Method for the safe administration of fatty acids |
| 08/16/1994 | US5338858 Viricides |
| 08/16/1994 | US5338837 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
| 08/16/1994 | US5338733 Bactericides |
| 08/16/1994 | US5338732 Megestrol acetate formulation |
| 08/16/1994 | US5338728 Pradimicin compounds |
| 08/16/1994 | US5338683 Genetic engineering, vaccines |
| 08/16/1994 | US5338543 Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
| 08/16/1994 | CA2115532A1 Pseudopeptides having an antiviral action |
| 08/16/1994 | CA1331445C Vaccine against e. coli septicaemia in poultry |
| 08/16/1994 | CA1331444C Ibdv production in continuous lines |
| 08/12/1994 | CA2114183A1 Pyridinium derivatives |
| 08/12/1994 | CA2113972A1 Orally active antifungal agents |
| 08/10/1994 | EP0610078A1 Cytotoxic and antiviral compound |
| 08/10/1994 | EP0610076A1 Cytotoxic compounds |
| 08/10/1994 | EP0609905A1 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones |
| 08/10/1994 | EP0609625A1 Inhibitors of HIV protease useful for the treatment of AIDS |
| 08/10/1994 | EP0609606A1 Tucaresol as an immunopotentiatory agent |
| 08/10/1994 | EP0609580A1 Recombinant CMV neutralising proteins |
| 08/10/1994 | EP0609393A1 VIRULENCE ASSOCIATED PROTEINS IN $i(BORRELIA BURGDORFERI (Bb)) |
| 08/10/1994 | EP0609221A1 Antimicrobial dialdehyde composition and methods of use. |
| 08/10/1994 | EP0609211A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 08/10/1994 | EP0555358B1 Anthracycline analogues bearing latent alkylating substituents |
| 08/10/1994 | EP0524997B1 2'-o-alkyl nucleotides and polymers containing them |